Rabbit model for human EBV-associated hemophagocytic syndrome (HPS): Sequential autopsy analysis and characterization of IL-2-dependent cell lines established from Herpesvirus papio-induced fatal rabbit lymphoproliferative diseases with HPS

American Journal of Pathology

Volumn 162, Issue 5, 2003, Pages 1721-1736

  Hayashi, Kazuhiko ^a   Jin, Zaishun ^a   Onoda, Sachiyo ^a   Joko, Hiromasa ^a   Teramoto, Norihiro ^a   Ohara, Nobuya ^a   Oda, Wakako ^a   Tanaka, Takehiro ^a   Liu, Yi Xuan ^a   Koirala, Tirtha Raj ^a   Oka, Takashi ^a   Kondo, Eisaku ^a   Yoshino, Tadashi ^a   Takahashi, Kiyoshi ^b   Akagi, Tadaatsu ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD79A ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CELL INFILTRATION; CLONAL VARIATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FATALITY; GENE EXPRESSION; HEMOPHAGOCYTIC SYNDROME; HERPES VIRUS; HISTIOCYTOSIS; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; IN SITU HYBRIDIZATION; INFECTIOUS MONONUCLEOSIS; KARYOTYPE; LYMPHADENITIS; LYMPHOID CELL; LYMPHOPROLIFERATIVE DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RABBIT; SCID MOUSE; SOUTHERN BLOTTING; SPLENOMEGALY; T LYMPHOCYTE;

EID: 0037408110     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64306-4     Document Type: Article

References (57)

1. Epstein MA, Achong BG, Barr YM: Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964, 1:702-703
2. Rickinson AB, Kieff E: Epstein-Barr virus. Fields Virology. Edited by Knipe DM, Howley PM. Philadelphia, Lippincott Williams & Wilkins, 2001, pp 2575-2627
3. Weiss LM, Movahed LA, Warnke R, Sklar J: Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 1989, 320:502-506
4. Chang KL, Chen YY, Shibata D, Weiss LM: Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol 1992, 1:246-255
5. Weiss LM, Chang KL: Association of the Epstein-Barr virus with hematolymphoid neoplasia. Adv Anat Pathol 1996, 3:1-15
6. Anagnostopoulos I, Hummel M: Epstein-Barr virus in tumours. Histopathology 1996, 29:297-315
7. Kawa K: Epstein-Barr virus: associated diseases in humans. Int J Hematol 2000, 71:108-117
8. Favara BE: Hemophagocytic lymphohistiocytosis: a hemophagocytic syndrome. Semin Diagn Pathol 1992, 9:63-74
9. Su IJ, Hsu YH, Lin MT, Cheng AL, Wang CH, Weiss LM: Epstein-Barr virus-containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis. Cancer 1993, 72:2019-2027
10. Su IJ, Chen RL, Lin DT, Lin KS, Chen CC: Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. Am J Pathol 1994, 144:1219-1225
11. Su IJ, Wang CH, Cheng AL, Chen RL: Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management. Leuk Lymphoma 1995, 19:401-406
12. Kikuta H: Epstein-Barr virus-associated hemophagocytic syndrome. Leuk Lymphoma 1995, 16:425-429
13. Okano M, Gross TG: Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis. Am J Hematol 1996, 53:111-115
14. Fisman DN: Hemophagocytic syndromes and infection. Emerg Infect Dis 2000, 6:601-608
15. Mroczek EC, Weisenburger DD, Grierson HL, Markin R, Purtilo DT: Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. Arch Pathol Lab Med 1987, 111:530-535
16. Gaffey MJ, Frierson Jr HF, Medeiros LJ, Weiss LM: The relationship of Epstein-Barr virus to infection-related (sporadic) and familial hemophagocytic syndrome and secondary (lymphoma-related) hemophagocytosis: an in situ hybridization study. Hum Pathol 1993, 24:657-667
17. Yamashita S, Murakami C, Izumi Y, Sawada H, Yamazaki Y, Yokota TA, Matsumoto N, Matsukura S: Severe chronic active Epstein-Barr virus infection accompanied by virus-associated hemophagocytic syndrome, cerebellar ataxia, and encephalitis. Psychiatry Clin Neurosci 1998, 52:449-452
18. Craig FE, Clare CN, Sklar JL, Banks PM: T-cell lymphoma and the virus-associated hemophagocytic syndrome. Am J Clin Pathol 1992, 97:189-194
19. Dolezal MV, Kamel OW, van de Rijn M, Cleary ML, Sibley RK, Warnke RA: Virus-associated hemophagocytic syndrome characterized by clonal Epstein-Barr virus genome. Am J Clin Pathol 1995, 103:189-194
20. Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ: Up-regulation of tumor necrosis factor-α gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest 1997, 100:1969-1979
21. Chen JS, Tzeng CC, Tsao CJ, Su WC, Chen TY, Jung YC, Su IJ: Clonal karyotype abnormalities in EBV-associated hemophagocytic syndrome. Haematologica 1997, 82:572-576
22. Ito E, Kitazawa J, Arai K, Otomo H, Endo Y, Imashuku S, Yokoyama M: Fatal Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with clonal karyotype abnormality. Int J Hematol 2000, 71:263-265
23. Yagita M, Iwakura H, Kishimoto T, Okamura T, Kunitomi A, Tabata R, Konaka Y, Kawa K: Successful allogeneic stem cell transplantation from an unrelated donor for aggressive Epstein-Barr virus-associated clonal T-cell proliferation with hemophagocytosis. Int J Hematol 2001, 74:451-454
24. Falk LA: A review of herpesvirus papio, a B-lymphotropic virus of baboons related to EBV. Comp Immun Microbiol Infect Dis 1979, 2:257-264
25. Franken M, Devergne O, Rosenzweig M, Annis B, Kieff E, Wang F: Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1. J Virol 1996, 70:7819-7826
26. Yates JL, Camiolo SM, Ali S, Ying A: Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function. Virology 1996, 222:1-13
27. Fuentes-Panana EM, Swaminathan S, Ling PD: Transcriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15). J Virol 1999, 73:826-833
28. Jenson HB, Ench Y, Gao SJ, Rice K, Carey D, Kennedy RC, Arrand JR, Mackett M: Epidemiology of herpesvirus papio infection in a large captive baboon colony: similarities to Epstein-Barr virus infection in humans. J Infect Dis 2000, 181:1462-1466
29. Hayashi K, Ohara N, Teramoto N, Onoda S, Chen HL, Oka T, Kondo E, Yoshino T, Takahashi K, Yates J, Akagi T: An animal model for human EBV-associated hemophagocytic syndrome: herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits. Am J Pathol 2001, 158:1533-1542
30. Howe JG, Shu MD: Isolation and characterization of the genes for two small RNAs of herpesvirus papio and their comparison with Epstein-Barr virus-encoded EBER RNAs. J Virol 1988, 62:2790-2798
31. Ling PD, Ryon JJ, Hayward SD: EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif. J Virol 1993, 67:2990-3003
32. Hayashi K, Koirala T, Ino H, Chen H-L, Ohara N, Teramoto N, Yoshino T, Takahashi K, Yamada M, Nii S, Miyamoto K, Fujimoto K, Yoshikawa Y, Akagi T: Malignant lymphoma induction in rabbits by intravenous inoculation of Epstein-Barr virus-related herpesvirus from HTLV-II-transformed cynomolgus leukocyte cell line (Si-IIA). Int J Cancer 1995, 63:872-880
33. Hayashi K, Chen H-L, Yanai H, Koirala TR, Ohara N, Teramoto N, Oka T, Yoshino T, Takahashi K, Miyamoto K, Fujimoto K, Yoshikawa Y, Akagi T: Cyno-EBV (EBV-related herpesvirus from cynomolgus macaques) induces rabbit malignant lymphomas and their tumor cell lines frequently show specific chromosomal abnormalities. Lab Invest 1999, 79:823-835
34. Angiolillo AL, Lamoyi E, Bernstein KE, Mage RG: Identification of genes for the constant region of rabbit T-cell receptor β chains. Proc Natl Acad Sci USA 1985, 82:4498-4502
35. Isono T, Kim CJ, Seto A: Sequence and diversity of rabbit T-cell receptor γ chain genes. Immunogenetics 1995, 41:295-300
36. Quintanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma DW, Sorbara L, Raffeld M, Straus SE, Jaffe ES: Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome Blood 2000, 96:443-451
37. Kanegane H, Bhatia K, Gutierrez M, Kaneda H, Wada T, Yachie A, Seki H, Arai T, Kagimoto S, Okazaki M, Oh-ishi T, Moghaddam A, Wang F, Tosato G: A syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma. Blood 1998, 91:2085-2091
38. Nagata H, Numata T, Konno A, Mikata I, Kurasawa K, Hara S, Nishimura M, Yamamoto K, Shimizu N: Presence of natural killer-cell clones with variable proliferative capacity in chronic active EpsteinBarr virus infection. Pathol Int 2001, 51:778-785
39. Nagata H, Konno A, Kimura N, Zhang Y, Kimura M, Demachi A, Sekine T, Yamamoto K, Shimizu N: Characterization of novel natural killer (NK)-cell and γδ T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus Blood 2001, 97:708-713
40. Yoshioka M, Ishiguro N, Kikuta H. Analysis on latency type of EBV infection in EBV-associated hemophagocytic syndrome. Proceeding of 49th Annual Meeting of the Japanese Society for Virology, Osaka, 2001, p 251 (in Japanese)
41. Callan MF, Steven N, Krausa P, Wilson JD, Moss PA, Gillespie GM, Bell JI, Rickinson AB, McMichael AJ: Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat Med 1996, 2:906-911
42. Hayashi K, Ohara N, Koirala TR, Ino H, Chen HL, Teramoto N, Kondo E, Yoshino T, Takahashi K, Yamada M, Tomita N, Miyamoto K, Fujimoto K, Yoshikawa Y, Akagi T: HTLV-II non-integrated malignant lymphoma induction in Japanese white rabbits following intravenous inoculation of HTLV-II-infected simian leukocyte cell line (Si-IIA). Jpn J Cancer Res 1994, 85:808-818
43. Hayashi K, Akagi T: An animal model for Epstein-Barr virus (EBV)-associated lymphomagenesis in the human: malignant lymphoma induction of rabbits by EBV-related herpesvirus from cynomolgus. Pathol Int 2000, 50:85-97
44. Rickinson AB, Kieff E: Epstein-Barr virus. Fields Virology. Edited by Fields BN, Knipe DM, Howley PM. Philadelphia, Lippincott-Raven, 1996, pp 2397-2446
45. Koirala TR, Hayashi K, Chen H-L, Ino H, Kariya N, Yanai H, Choudhury CR, Akagi T: Malignant lymphoma induction of rabbits with oral spray of Epstein-Barr virus-related herpesvirus from Si-IIA cells (HTLV-II-transformed cynomolgus cell line): a possible animal model for Epstein-Barr virus infection and subsequent virus-related tumors in humans. Pathol Int 1997, 47:442-448
46. Chen H-L, Hayashi K, Koirala TR, Ino H, Fujimoto K, Yoshikawa Y, Choudhury CR, Akagi T: Malignant lymphoma induction in rabbits by oral inoculation of crude virus fraction prepared from Ts-B6 cells (cynomolgus B-lymphoblastoid cells harboring Epstein-Barr virus-related simian herpesvirus). Acta Med Okayama 1997, 51:141-147
47. Smith RD: Is Epstein-Barr virus a human oncogene or only an innocent bystander? Hum Pathol 1997, 28:1333-1335
48. Ambinder RF: γ herpesviruses and "hit-and-run" oncogenesis. Am J Pathol 2000, 156:1-3
49. Ohshima K, Suzumiya J, Kanda M, Kato A, Kikuchi M: Integrated and episomal forms of Epstein-Barr virus (EBV) in EBV-associated disease. Cancer Lett 1998, 122:43-50
50. Shimizu N, Tanabe-Tochikura A, Kuroiwa Y, Takada K: Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J Virol 1994, 68:6069-6073
51. Komano J, Maruo S, Kurozumi K, Oda T, Takada K: Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. J Virol 1999, 73:9827-9831
52. Ruf IK, Rhyne PW, Yang C, Cleveland JL, Sample JT: Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis. J Virol 2000, 74:10223-10228
53. Wutzler P, Meerbach A, Farber I, Wolf H, Scheibner K: Malignant lymphomas induced by an Epstein-Barr virus-related herpesvirus from Macaca arctoides: a rabbit model. Arch Virol 1995, 140:1979-1995
54. Ferrari MG, Rivadeneira ED, Jarrett R, Stevceva L, Takemoto S, Markham P, Franchini G: HV(MNE), a novel lymphocryptovirus related to Epstein-Barr virus, induces lymphoma in New Zealand White rabbits. Blood 2001, 98:2193-2199
55. Hayashi K, Ohara N, Fujiwara K, Aoki H, Jeon HJ, Takahashi K, Tomita N, Miyamoto K, Akagi T: Co-expression of CD4 and CD8 associated with elevated interleukin-4 in a cord T cell line derived by co-culturing normal human cord leukocytes and an HTLV-II-producing simian leukocyte cell line (Si-IIA). J Cancer Res Clin Oncol 1993, 119:137-141
56. Ohga S, Nomura A, Takada H, Ihara K, Kawakami K, Yanai F, Takahata Y, Tanaka T, Kasuga N, Hara T: Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection. J Infect Dis 2001, 183:1-7
57. van Laar JA, Buysse CM, Vossen AC, Hjalmarsson B, van Den Berg B, van Lom K, Deinum J: Epstein-Barr viral load assessment in immunocompetent patients with fulminant infectious mononucleosis. Arch Intern Med 2002, 162:837-839